Trellus Health® has announced its FY24 results with the performance coming in line with management expectations. 2025 is signalled to have started strongly, reflecting the previously announced pilot agreement with Johnson & Johnson which is presently in ramp up stage. Management reaffirms the current cash runway extends to October 2025. Given this, various funding options are under active consideration to provide the working capital for Trellus Health to continue its commercialisation journey an ....
